Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 550483

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

Diener, H.C.; Dodick, D.W.; Aurora, S.K.; Turkel, C.C.; DeGryse, R.E.; Lipton, R.B.; Silberstein, S.D.; Brin, M.F.; PREEMPT 2 Chronic Migraine Study Group; Becker, W.J. et al.
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial // Cephalalgia (Oslo), 30 (2010), 7; 804-814 doi:10.1177/0333102410364677 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 550483 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

Autori
Diener, H.C. ; Dodick, D.W. ; Aurora, S.K. ; Turkel, C.C. ; DeGryse, R.E. ; Lipton, R.B. ; Silberstein, S.D. ; Brin, M.F. ; PREEMPT 2 Chronic Migraine Study Group ; Becker, W.J. ; Blumenfeld, A. ; Cutrer, F.M. ; Gendolla, A. ; Lay, C. ; Martin, V. ; Relja, Maja ; Schim, J.D. ; Smith, T.R. ; Ward, T.W. ; Winner, P.

Izvornik
Cephalalgia (Oslo) (0333-1024) 30 (2010), 7; 804-814

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
chronic migraine; onabotulinumtoxinA; prophylaxis

Sažetak
The results of PREEMPT 2 demonstrate that onabotulinumtoxinA is effective for prophylaxis of headache in adults with chronic migraine. Repeated onabotulinumtoxinA treatments were safe and well tolerated.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Projekti:
108-1080003-0019 - Klinička farmakologija poremećaja pokreta (Relja, Maja, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Maja Relja (autor)

Poveznice na cjeloviti tekst rada:

doi cep.sagepub.com www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Diener, H.C.; Dodick, D.W.; Aurora, S.K.; Turkel, C.C.; DeGryse, R.E.; Lipton, R.B.; Silberstein, S.D.; Brin, M.F.; PREEMPT 2 Chronic Migraine Study Group; Becker, W.J. et al.
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial // Cephalalgia (Oslo), 30 (2010), 7; 804-814 doi:10.1177/0333102410364677 (međunarodna recenzija, članak, znanstveni)
Diener, H., Dodick, D., Aurora, S., Turkel, C., DeGryse, R., Lipton, R., Silberstein, S., Brin, M., PREEMPT 2 Chronic Migraine Study Group & Becker, W. (2010) OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia (Oslo), 30 (7), 804-814 doi:10.1177/0333102410364677.
@article{article, author = {Diener, H.C. and Dodick, D.W. and Aurora, S.K. and Turkel, C.C. and DeGryse, R.E. and Lipton, R.B. and Silberstein, S.D. and Brin, M.F. and Becker, W.J. and Blumenfeld, A. and Cutrer, F.M. and Gendolla, A. and Lay, C. and Martin, V. and Relja, Maja and Schim, J.D. and Smith, T.R. and Ward, T.W. and Winner, P.}, year = {2010}, pages = {804-814}, DOI = {10.1177/0333102410364677}, keywords = {chronic migraine, onabotulinumtoxinA, prophylaxis}, journal = {Cephalalgia (Oslo)}, doi = {10.1177/0333102410364677}, volume = {30}, number = {7}, issn = {0333-1024}, title = {OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial}, keyword = {chronic migraine, onabotulinumtoxinA, prophylaxis} }
@article{article, author = {Diener, H.C. and Dodick, D.W. and Aurora, S.K. and Turkel, C.C. and DeGryse, R.E. and Lipton, R.B. and Silberstein, S.D. and Brin, M.F. and Becker, W.J. and Blumenfeld, A. and Cutrer, F.M. and Gendolla, A. and Lay, C. and Martin, V. and Relja, Maja and Schim, J.D. and Smith, T.R. and Ward, T.W. and Winner, P.}, year = {2010}, pages = {804-814}, DOI = {10.1177/0333102410364677}, keywords = {chronic migraine, onabotulinumtoxinA, prophylaxis}, journal = {Cephalalgia (Oslo)}, doi = {10.1177/0333102410364677}, volume = {30}, number = {7}, issn = {0333-1024}, title = {OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial}, keyword = {chronic migraine, onabotulinumtoxinA, prophylaxis} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.